A primary care "friendly" cognitive behavioral insomnia therapy

Sleep

Volumn 26, Issue 2, 2003, Pages 177-182

  Edinger, Jack D ^a,b,d   Sampson, William S ^a,c  

^a Apartment No 1307   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cognitive behavioral therapy; Primary care; Primary insomnia; Sleep hygiene

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MALE; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP; SOLDIER; STATISTICAL ANALYSIS; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

COGNITIVE THERAPY; CULTURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PRIMARY HEALTH CARE; QUESTIONNAIRES; SINGLE-BLIND METHOD; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0037564853     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/26.2.177     Document Type: Article

References (47)

1. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and ils treatment: prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32.
2. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 1989;262:1479-84.
3. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: result from upper Bavarian field study. Sleep 1991;14:392-8.
4. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years Sleep 1999;22 (suppl 2.):S366-72.
5. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatric Res 1997;31:333-46
6. Zammit GR, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22 (Suppl. 2):S379-85.
7. Gislason T, Almqvist M. Somatic disease and sleep complaints: an epidemiological study of 3201 Swedish men Acta Med Scand 1987;221:475-81.
8. Vollrath M, Wicki W, Angst J. The Zurich study-VlII Insomnia: association with depression, anxiety, somatic syndromes and course of insomnia. Eur Arch Psychiatry Neurol Sci 1989;239:113-24.
9. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105-14.
10. Johnson EO, Roehrs T, Roth T, Breslau N. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep, 1998; 21: 178-186.
11. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23.
12. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997;19:245-50.
13. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacologic treatment of insomnia. Sleep 1999;22:371-5
14. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF 3rd, Kupfer DJ Benzodiazepmes and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997;278:2170-7.
15. Nowell PD, Reynolds CF III, Buysse DJ, Dew MA, Kupfer DJ. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 1999;60:89-95.
16. Tsutsui S A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. J Inter Med Res 2001;29:163-77.
17. Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001;62:453-63.
18. Greenblatt DJ. Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry 1992;53:7-13.
19. Kales A, Bixler EO, Tan TL, Scharf MB, Kales JD Chronic hypnotic use ineffectiveness, drug withdrawal insomnia and hypnotic drug dependence. JAMA 1974;227:513
20. Johnson LC, Chernik DA. Sedative hypnotics and human performance. Psychopharmacology 1982;76:101-13.
21. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton J Psychotropic drug use and the role of hip fracture N Engl J Med 1987;316:363-69.
22. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assimus JD, Garfinket L Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998;43:687-93
23. Morin CM, Gaulier B, Barry T, Kowatch RA Patients' acceptance of psychological and pharmacological therapies for insomnia. Sleep 1992;15:302-05.
24. Vincent N, Lionberg C Treatment preference and patient satisfaction in chronic insomnia. Sleep 2001;24:411-7.
25. Hoelscher TJ, Edinger JD. Treatment of sleep-maintenance insomnia in older adults sleep period reduction, sleep education and modified stimulus control Psychol Aging 1988;3:258-63.
26. Edinger JD, Hoelscher TJ, Marsh GR, Ionescu-Pioggia M, Lipper S A cognitive-behavioral therapy for sleep-maintenance insomnia in older adults Psychol Aging 1992;7:282-9.
27. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Efficacy of cognitive-behavioral therapy for treating primary sleep-maintenance insomnia. JAMA 2001;285:1856-64.
28. Morin CM, Kowatch RA, Barry T, Walton E. Cognitive-behavior therapy for late-life insomnia. J Consult Clin Psychol 1993;61:137-47.
29. Morin, CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia, a randomized controlled trial. JAMA 1999;281:991-1035.
30. Espie CA, Brindle S, Tessier S, et al. Supervised cognitive-behavioral therapy for insomnia in general medical practice - preliminary results from the West of Scotland programme. In Sanavio E, ed Behavior and cognitive therapy today essays in honour of Hans J Eysenck. Amsterdam: Elsevier, 1998
31. Morin CM, Kowatch RA, Wade JB. Behavioral management of steep disturbances secondary to chronic pain. J Behav Ther Exp Psychiatry 1989;20:295-302.
32. Currie SR, Wilson KG Ponteftact AJ, deLaplante L. Cognitive-behavioral treatment of insomnia secondary to chronic pain J Consult Clin Psychol 2000;68:407-16.
33. Blais FC, Mimeault V, Monn CM. Treatment of comorbid insomnia and anxiety disorders. Sleep Res 1997;26:372.
34. Morin CM, Stone J, McDonald K, Jones S. Psychological management of insomnia a clinical replication series with 100 patients. Behav Ther 1994;25:291-309.
35. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia Sleep 1999;22:1134-56.
36. Richardson GS Managing insomnia in the primary care setting: raising issues Sleep, 2000;23 (Suppl. 1):S9-12
37. Mimeault V. Morin CM. Self-help treatment for insomnia, bibliotherapy with and without professional guidance J Consult Ctin Psychol 1999;67:511-519.
38. th ed. Washington, DC. American Psychiatric Association 1994
39. Edinger, JD. Structured Interview for Sleep Disorders. Unpublished document.
40. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10:45-55.
41. Lacks P. Behavioral treatment for persistent insomnia. New York: Pergamon Press, 1987.
42. Morin CM Insomnia: psychological assessment and management New York: Guillford Press, 1993.
43. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972;3:247-60.
44. Espie CA, Inglis SJ, Harvey L. Predicting clinically significant response to cognitive behavior therapy for chronic insomnia in general medical practice: analysis of outcome data at 12 months posttreatment J Consult Clin Psychol 2001;69:58-66.
45. Frison L, Pocock SJ. Repeated measures in clinical trials analysis using mean summary statistics and its implications for design Statistics in Medicine 1992;11:1685-704.
46. Overall JE, Ashby B. Baseline corrections in experimental and quasi-experimental clinical trials. Neuropsychopharmacology 1991;4:273-81
47. Llabre MM, Spitzer SB, Saab PG, Ironson GH, Schneiderman N The reliability and specificity of delta versus residualized change as measures of cardiovascular reactivity to behavioral challenges. Psychophysiology 1991;28:701-11.